Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Dana-Farber Cancer Institute
Related studies linked through entity extraction aliases.
Multiple Risk Behavior Intervention in Health Care Settings
- Status
- COMPLETED
- Phase
- NA
SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)
- Status
- COMPLETED
- Phase
- N/A
Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE1
Image-Guided Gynecologic Brachytherapy
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Enhancing Adherence and Knowledge of Erlotinib in Patients Wtih Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Human Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
- Status
- COMPLETED
- Phase
- N/A
Exercise and Metformin in Colorectal and Breast Cancer Survivors
- Status
- COMPLETED
- Phase
- PHASE2
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
- Status
- TERMINATED
- Phase
- PHASE1
Bosutinib in Adult Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
Effectiveness of Open and Robotic Prostatectomy
- Status
- COMPLETED
- Phase
- N/A
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate
- Status
- COMPLETED
- Phase
- N/A
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Amgen 386 for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
IL-2 "SELECT" Tissue Collection Protocol in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- N/A
Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation
- Status
- COMPLETED
- Phase
- PHASE2